IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 325 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $9,483 | -17.5% | 265,330 | -12.8% | 0.08% | -52.7% |
| Q4 2022 | $11,497 | -96.0% | 304,390 | +4643.5% | 0.17% | +4075.0% |
| Q3 2022 | $284,000 | -79.6% | 6,417 | -82.9% | 0.00% | -76.5% |
| Q2 2022 | $1,392,000 | +131.2% | 37,590 | +90.0% | 0.02% | +183.3% |
| Q4 2021 | $602,000 | +119.7% | 19,788 | +142.1% | 0.01% | +50.0% |
| Q3 2021 | $274,000 | -78.2% | 8,173 | -69.2% | 0.00% | -84.0% |
| Q3 2020 | $1,258,000 | +347.7% | 26,507 | +346.7% | 0.02% | +66.7% |
| Q1 2020 | $281,000 | 0.0% | 5,934 | +27.5% | 0.02% | +200.0% |
| Q4 2019 | $281,000 | -94.6% | 4,654 | -92.7% | 0.01% | -98.7% |
| Q1 2019 | $5,156,000 | +1636.0% | 63,522 | +1054.9% | 0.38% | +1728.6% |
| Q4 2018 | $297,000 | – | 5,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
| M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
| Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
| Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
| BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
| Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
| Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
| Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
| Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
| SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |